[ 1 ] Wang W, Yeung KWK. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact Mater 2017;2(4):224‒47. 链接1

[ 2 ] Winkler T, Sass FA, Duda GN, Schmidt-Bleek K. A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering. Bone Joint Res 2018;7(3):232‒43. 链接1

[ 3 ] Kaur M, Singh K. Review on titanium and titanium based alloys as biomaterials for orthopaedic applications. Mater Sci Eng C 2019;102:844‒62. 链接1

[ 4 ] Pierannunzii L, Zagra L. Bone grafts, bone graft extenders, substitutes and enhancers for acetabular reconstruction in revision total hip arthroplasty. EFORT Open Rev 2016;1(12):431‒9. 链接1

[ 5 ] Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J 2016;98-B (1 Suppl A):6‒9. 链接1

[ 6 ] Sakkas A, Wilde F, Heufelder M, Winter K, Schramm A. Autogenous bone grafts in oral implantology—is it still a “gold standard”? A consecutive review of 279 patients with 456 clinical procedures. Int J Implant Dent 2017;3(1):23. 链接1

[ 7 ] Roseti L, Parisi V, Petretta M, Cavallo C, Desando G, Bartolotti I, et al. Scaffolds for bone tissue engineering: state of the art and new perspectives. Mater Sci Eng C 2017;78:1246‒62. 链接1

[ 8 ] Sanz M, Dahlin C, Apatzidou D, Artzi Z, Bozic D, Calciolari E, et al. Biomaterials and regenerative technologies used in bone regeneration in the craniomaxillofacial region: consensus report of group 2 of the 15th European Workshop on Periodontology on Bone Regeneration. J Clin Periodontol 2019;46:82‒91. 链接1

[ 9 ] Agarwal R, García AJ. Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair. Adv Drug Deliv Rev 2015;94:53‒62. 链接1

[10] Skaggs DL, Samuelson MA, Hale JM, Kay RM, Tolo VT. Complications of posterior iliac crest bone grafting in spine surgery in children. Spine 2000;25(18):2400‒2. 链接1

[11] Colo E, Rijnen WHC, Schreurs BW. The biological approach in acetabular revision surgery: impaction bone grafting and a cemented cup. Hip Int 2015;25(4):361‒7. 链接1

[12] Issack PS, Nousiainen M, Beksac B, Helfet DL, Sculco TP, Buly RL. Acetabular component revision in total hip arthroplasty. Part II: management of major bone loss and pelvic discontinuity. Am J Orthop 2009;38(11):550‒6.

[13] Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN; American Academy of Orthopaedic Surgeons, The Committee on Biological Implants. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am 2001;83-A(Suppl 2 Pt 2):98‒103. 链接1

[14] Sang T, Li S, Ting HK, Stevens MM, Becer CR, Jones JR. Hybrids of silica/poly (caprolactone coglycidoxypropyl trimethoxysilane) as biomaterials. Chem Mater 2018;30(11):3743‒51. 链接1

[15] Saigo L, Kumar V, Liu Y, Lim J, Teoh SH, Goh BT. A pilot study: clinical efficacy of novel polycaprolactone‍‒‍tricalcium phosphate membrane for guided bone regeneration in rabbit calvarial defect model. J Oral Max Surg Med 2018;30(3):212‒9. 链接1

[16] Nasajpour A, Ansari S, Rinoldi C, Rad AS, Aghaloo T, Shin SR, et al. A multifunctional polymeric periodontal membrane with osteogenic and antibacterial characteristics. Adv Funct Mater 2018;28(3):1703437. 链接1

[17] Huang B, Caetano G, Vyas C, Blaker JJ, Diver C, Bártolo P. Polymer-ceramic composite scaffolds: the effect of hydroxyapatite and β-tri-calcium phosphate. Materials 2018;11(1):129. 链接1

[18] Cristofaro F, Gigli M, Bloise N, Chen H, Bruni G, Munari A, et al. Influence of the nanofiber chemistry and orientation of biodegradable poly(butylene succinate)‍-based scaffolds on osteoblast differentiation for bone tissue regeneration. Nanoscale 2018;10(18):8689‒703. 链接1

[19] Domingos M, Gloria A, Coelho J, Bartolo P, Ciurana J. Three-dimensional printed bone scaffolds: the role of nano-/micro-hydroxyapatite particles on the adhesion and differentiation of human mesenchymal stem cells. Proc Inst Mech Eng H 2017;231(6):555‒64. 链接1

[20] Haugen HJ, Lyngstadaas SP, Rossi F, Perale G. Bone grafts: which is the ideal biomaterial? J Clin Periodontol 2019;46(Suppl 21):92‒102. 链接1

[21] Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng 2012;40(5):363‒408. 链接1

[22] Athanasiou VT, Papachristou DJ, Panagopoulos A, Saridis A, Scopa CD, Megas P. Histological comparison of autograft, allograft-DBM, xenograft, and synthetic grafts in a trabecular bone defect: an experimental study in rabbits. Med Sci Monit 2010;16(1):BR24‒31.

[23] Meloni SM, Jovanovic SA, Pisano M, Xhanari E, De Riu G, Tullio A, et al. Sinus lift grafting with anorganic bovine bone vs 50% autologous bone mixed with 50% anorganic bovine bone: 2 years after loading results from a randomized controlled trial. Eur J Oral Implantol 2017;10(4):425‒32.

[24] Cheng L, Wang Yi, Sun G, Wen S, Deng L, Zhang H, et al. Hydration-enhanced lubricating electrospun nanofibrous membranes prevent tissue adhesion. Research 2020;2020:1‒12. 链接1

[25] Chen W, Tian X, He W, Li J, Feng Y, Pan G. Emerging functional materials based on chemically designed molecular recognition. BMC Materials 2020;2(1):1. 链接1

[26] Qian Y, Shen Y, Deng S, Liu T, Qi F, Lu Z, et al. Dual functional β‍-peptide polymer-modified resin beads for bacterial killing and endotoxin adsorption. BMC Materials 2019;1(1):5. 链接1

[27] D’Alessandro D, Perale G, Milazzo M, Moscato S, Stefanini C, Pertici G, et al. Bovine bone matrix/poly(L-lactic-co-‍ε‍-caprolactone)/gelatin hybrid scaffold (SmartBone®) for maxillary sinus augmentation: a histologic study on bone regeneration. Int J Pharm 2017;523(2):534‒44. 链接1

[28] Facciuto E, Grottoli CF, Mattarocci M, Illiano F, Compagno M, Ferracini R, et al. Three-dimensional craniofacial bone reconstruction with SmartBone® on demand. J Craniofac Surg 2019;30(3):739‒41. 链接1

[29] Grottoli CF, Cingolani A, Zambon F, Ferracini R, Villa T, Perale G. Simulated performance of a xenohybrid bone graft (SmartBone®) in the treatment of acetabular prosthetic reconstruction. J Funct Biomater 2019;10(4):53. 链接1

[30] Cingolani A, Grottoli CF, Esposito R, Villa T, Rossi F, Perale G. Improving bovine bone mechanical characteristics for the development of xenohybrid bone grafts. Curr Pharm Biotechnol 2019;19(12):1005‒13. 链接1

[31] van den Bosch E, Gielens C. Gelatin degradation at elevated temperature. Int J Biol Macromol 2003;32(3-5):129‒38. 链接1

[32] Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects. Eur J Oral Implantol 2009;2(4):247‒66.

[33] Leijten J, Chai YC, Papantoniou I, Geris L, Schrooten J, Luyten FP. Cell based advanced therapeutic medicinal products for bone repair: keep it simple? Adv Drug Deliv Rev 2015;84:30‒44. 链接1

[34] Gallop PM, Lian JB, Hauschka PV. Carboxylated calcium-binding proteins and vitamin K. N Engl J Med 1980;302(26):1460‒6. 链接1

[35] McKee MD, Cole WG. Bone matrix and mineralization. In: Glorieux FH, Pettifor JM, Jüppner H, editors. Pediatric bone. San Diego: Academic Press; 2012. p.9‒37. 链接1

[36] Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N. Characterization of a ccarboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 1976;73(5):1447‒51. 链接1

[37] Eastell R, Hannon RA. Biochemical markers of bone turnover. In: Lobo RA, editor. Treatment of the postmenopausal woman. St. Louis: Academic Press; 2007. p. 337‒49. 链接1

[38] Hall BK, Part I. Vertebrate skeletal tissues. In: Hall BK, editor. Bones and cartilage. San Diego: Academic Press; 2015. p. 1. 链接1

[39] Maeda H, Wada N, Tomokiyo A, Monnouchi S, Akamine A. Prospective potency of TGF-a1 on maintenance and regeneration of periodontal tissue. In: Jeon KW, editor. International review of cell and molecular biology. New York: Academic Press; 2013. p. 283‒367. 链接1

[40] Butler WT. The nature and significance of osteopontin. Connect Tissue Res 1989;23(2‒3):123‒36.

[41] Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000;11(3):279‒303. 链接1

[42] Chabas D. L’ostéopontine, une molécule aux multiples facettes. Med Sci 2005;21(10):832‒8. French. 链接1

[43] Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000;19(7):615‒22. 链接1

[44] Nikel O, Laurencin D, McCallum SA, Gundberg CM, Vashishth D. NMR investigation of the role of osteocalcin and osteopontin at the organic‒inorganic interface in bone. Langmuir 2013;29(45):13873‒82. 链接1

[45] Dashdulam D, Kim ID, Lee H, Lee HK, Kim SW, Lee JK. Osteopontin heptamer peptide containing the RGD motif enhances the phagocytic function of microglia. Biochem Biophys Res Commun 2020;524(2):371‒7. 链接1

[46] Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993;7(15):1475‒82. 链接1

[47] Kaminska B. Role of osteopontin‍‒‍integrin signalling in glioma‍‒‍microglia crosstalk. FEBS Open Bio 2019;9:33.

[48] Schett G, Redlich K, Smolen JS. The role of osteoprotegerin in arthritis. Arthritis Res Ther 2003;5(5):239‒45. 链接1

[49] Lories RJU, Luyten FP. Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. Clin Rheumatol 2001;20(1):3‒9. 链接1

[50] Yeung RSM. The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss. J Rheumatol 2004;31(5):844‒6.

[51] Kurban S, Mehmetoglu I. Osteoprotegerin, RANK and RANK ligand. Turk J Biochem 2007;32(4):178‒84.

[52] Martin TJ, Romas E, Gillespie MT. Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 1998;8(2):107‒23. 链接1

[53] Wang T, He C. TNF-a and IL-6: the link between immune and bone system. Curr Drug Targets 2020;21(3):213‒27. 链接1

[54] Williams DF. On the mechanisms of biocompatibility. Biomaterials 2008;29(20):2941‒53. 链接1

[55] Murphy CM, Haugh MG, O’‍Brien FJ. The effect of mean pore size on cell attachment, proliferation and migration in collagen‍‒‍glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010;31(3):461‒6. 链接1